1.Recent advances in treatment of wet age-related macular degeneration
International Eye Science 2015;(2):251-254
Age-related macular degeneration ( AMD ) is one of the important eye diseases of the WHO present three big blindness, is one of the main blinding eye disease in people over the age of 50, people over the age of 65, about 2% of the disease caused by monocular blindness, as the population ages, AMD prevalence is increasing in our country. AMD with respect to its clinical manifestations can be divided into dry AMD and wet AMD, wet AMD is the most harmful for the vision of patients, at present there are many treatments for AMD ( mainly for wet age-related macular degeneration ) , mainly including laser treatment, drug therapy, surgical treatment, gene therapy, etc. The treatments of AMD would be illuminated in this article.
2.Clinical Curative Effect Observation on Treatment of Chronic Obstructive Pulmonary Disease in Exacerbation Stage with Aerosol Inhalation of Budesonide Combined with Chinese Herbal Enema
International Journal of Traditional Chinese Medicine 2009;31(5):428-
Objective To observe clinical effect of treating chronic obstructive pulmonary disease(COPD) in exacerbation stage with aerosol inhalation of budesonide combined with Chinese herbal enema. Methods 36 cases with COPD were randomly recurited into a control group and a treatment group. The control group was treated with routine western medicine, and the treatment group was treated with aerosol inhalation of budesonide combined with Chinese herbal enema. The clinical effect was observed in both groups, Results The total effective rate in the treatment group and the control group was 88.9% and 72.2%, respectively, showing significant difference between the two group. (P<0.05) .Conclusion The treatment of aerosol inhalation of budesonide combined with Chinese herbal enema on COPD is better than routine western medicine.
3.Observation on Clinical Curative Effect of SCH 1000 Combined with Tanreqing on COPD
International Journal of Traditional Chinese Medicine 2009;31(3):237-
Objective To observe the clinical curative effect of SCH 1000 combined with Tanreqing on chronic obstructive pulmonary diseases(COPD). Methods 96 patients with COPD were randomly recruited into a control group and a treatment group. The control group was treated with SCH 1000 aerosol and the treatment group was treated with SCH 1000 aerosol combined with Tanreqing injection. Results The treatment group had better clinical curative effects than the control group, with (P<0.05) .Conclusion The treatment of SCH 1000 combined with Tanreqing on COPD is effective.
4. Study on prescription technology of Compound Zhizi Gel
Chinese Traditional and Herbal Drugs 2013;44(21):2982-2987
Objective: To optimize the prescription of Compound Zhizi Gel (CZG) and to optimize the prescription technology of CZG. Methods: Orthogonal test, cold-resistant and heat-resistant tests were used to optimize the prescription technology. Using spreadability, glossiness, evenness, centrifugal stability, and in vitro transdermal diffusion as indexes, other excipients of prescription were optimized. Results: The optimal CZG prescription was Carbopol 940-glycerin-propylene glycol-triethanolamine-azone (1.5%:1.5%:3%:5%:5%). Conclusion: The optimized prescription is reliable and stable. It could meet the production requirements of CZG.
6.Nodular regenerative hyperplasia of the liver:a clinical study of 12 cases
Li-Ming ZHU ; Jia-Ming QIAN ; Wei-Xun ZHOU ;
Chinese Journal of Digestion 2001;0(10):-
Objective To review the clinical,histological and diagnostic aspects of 12 documented cases of nodular regenerative hyperplasia of the liver(NRHL),to make this condition be understood and dealt with better. Method Twelve NRHL cases were diagnosed based on liver biopsy from 300 portal hypertension patients who had been underwent splenectomy.Imaging studies were performed as part of the diagnostic evaluation.Clinical manifestation and biochemical tests were recorded at the time of diagnosis.Management and prognosis were also reviewed.Results Most patients were complicated with autoimmune disease,6 cases were diagnosed systemic lupus erythematosus and 1 was Crohn's disease and 1 suspected ulcerative colitis.Six cases were treated by prednisone and 3 cases by immunosuppressant.Eleven cases had suffered from portal hypertension.All cases had no history of viral hepatitis.Biochemical tests showed mild increase of liver enzyme and relative normal synthetic liver function.The histological finding was nodular in the hepatic parenehyma,with mild periportal fibrosis,intraportal lymphocytic infiltration,narrow and obstruction of branch of portal vein,and lack of hepatocyte necrosis.All cases were diagnosed liver cirrhosis and portal hypertension before operation.Management was directed to portal hypertension and varices bleeding with satisfactory results.Most of them keep a stable condition during the follow-up. Conclusion The NRHL was uncommon and its cause and pathogenesis was unclear,may be related with immune and hepatic blood circulation disorder.It should be considered in patients with unexplained portal hypertension and distinguished it from liver cirrhosis.Liver biopsy confirms the diagnosis.Management directed to portal hypertension may improve clinical condition.
7.Observation on 120 cases of pulmonary infection of the aged people treated with the combination of traditional Chinese medicine and western medicine
Li LIU ; Ming WEI ; Hongmei ZHANG
International Journal of Traditional Chinese Medicine 2010;32(3):225-226
Objective To observe the effects of treating pulmonary infection of the aged people with the combination of TCM and WM.Methods A total of 120 the aged patients with pulmonary infection were randomly recruited into a control group and a treatment group,60 patients in each.The control group was treated with cefoperazone,sulbactam intravenously drop and inhalation of low flow oxygen(1~2L/min,2~4h,once/day),while the treatment group was added modified Xiaocaihu decoction and Shengmai injection on the basis of the control group.Both groups were treated for 14 days.Results The significant effective rate was 63.3%and 45.0%in the treatment group and the control group respectively,showing significant difference(U=0.5248,P<0.01).The effective rate was 96.7%and 83.3%in the treatment group and the control group respectively,also showing significant difference(U=0.5314,P<0.05).Conclusion It is effective to treat pulmonary infection of the aged patients with modified Xiaocaihu decoction and Shengmai decoction together with western medicine.
9.Reliability and validity of the Chinese version of Interpersonal Stress-Coping Inventory for undergraduates
Ming LI ; Shuqin PANG ; Wei SHAO
Chinese Mental Health Journal 2010;24(1):55-58
Objective:To evaluate the reliability and validity of the Chinese version of Interpersonal Stress-Coping Inventory for Undergraduates(ISI).Methods:Totally 421 college students of 1~3 grades in two colleges of Anhui province were selected.They were asked to complete the ISI and Simplified Coping Style Questionnaire(SCSQ)at the same time to test the reliability and validity of ISI.Two weeks later,52 of them were retested to test the re-test reliability.Results:Cronbach α of the Chinese version of ISI was 0.79,re-test reliability was 0.87.ISI Scores were correlated with SCSQ scores(r=0.69).Exploratory factor analysis was applied to the data,and three subscales were derived:positive coping,negative coping,and dilution coping.The factor loadinps were 0.41~0.68.The explained variances were 14.82,14.10,and 7.06 respectively.Conclusion:The Chinese version of Interpersonal Stress-Coping Inventory has good psychometric quality and can be used in Chinese undergraduates of interpersonal stress coping research.
10.Effect of compound ezhu powder on serum levels of CA125 and CA19-9, and the expression of cyclin D protein in endometriosis patients.
Ming WEI ; Bao-Li CAO ; Yun LIU
Chinese Journal of Integrated Traditional and Western Medicine 2014;34(8):926-930
OBJECTIVETo study the effect of Compound Ezhu Powder (CEP) on serum levels of CA125 and CA19-9, and the expression of cyclin D protein in endometriosis patients, thus providing theoretical evidence for clinical application of CEP.
METHODSTotally 69 all endometriosis patients underwent surgical treatment at Department of Gynecology and Obstetrics, Tianjin Nankai Hospital from January 2011 to January 2013 were randomly assigned to group A (35 cases) and group B (34 cases). Meanwhile, 30 patients with uterine fibroids who prepared for surgical treatment during the same period were recruited as the control group. Patients in group A took EZP 3 months before surgery. No treatment was given to patients in group B and the control group. The serum CA125 level and the expression of cyclin D in the ectopic endometrium and the eutopic endometrium were detected in the 3 groups before surgery.
RESULTSThe expression of cyclin D was higher in group A and group B than in the control group (P < 0.05). The serum levels of CA125 and CA19-9 were significantly lower in group A than in group B (P < 0.05). The expression of cyclin D in the ectopic endometrium was lower in group A than in group B, but with no statistical difference (P > 0.05). The expression of cyclin D in the eutopic endometrium was significantly lower in group A than in group B with statistical difference (P < 0.05). Meanwhile, the serum CA125 level was positively correlated with the serum CA19-9 level (r = 0.45, P < 0.05).
CONCLUSIONSThe expression of cyclin D obviously increased in endometriosis patients, which was associated with the occurrence of endometriosis. CEP could lower serum levels of CA125 and CA19-9, and down-regulate the expression level of cyclin D, indicating its roles in inhibiting the cell cycle.
Adult ; Antigens, Tumor-Associated, Carbohydrate ; blood ; CA-125 Antigen ; blood ; CA-19-9 Antigen ; blood ; Cyclin D1 ; metabolism ; Drugs, Chinese Herbal ; pharmacology ; Endometriosis ; blood ; drug therapy ; Female ; Humans